1. Home
  2. SXTP vs VIVS Comparison

SXTP vs VIVS Comparison

Compare SXTP & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

N/A

Current Price

$0.90

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$0.16

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXTP
VIVS
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.8M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
SXTP
VIVS
Price
$0.90
$0.16
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $3.70
N/A
AVG Volume (30 Days)
126.3K
★ 670.2K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.77
N/A
EPS
N/A
★ N/A
Revenue
$1,005,471.00
★ $4,603,000.00
Revenue This Year
N/A
$228,144.28
Revenue Next Year
$70.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 65.49
8.82
52 Week Low
$0.34
$0.15
52 Week High
$8.62
$3.40

Technical Indicators

Market Signals
Indicator
SXTP
VIVS
Relative Strength Index (RSI) 36.73 23.53
Support Level $0.84 N/A
Resistance Level $1.63 $0.30
Average True Range (ATR) 0.14 0.02
MACD -0.04 0.00
Stochastic Oscillator 2.63 1.84

Price Performance

Historical Comparison
SXTP
VIVS

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Share on Social Networks: